Ten-day bismuth-containing quadruple therapy is effective as first-line therapy for Helicobacter pylori–related chronic gastritis: a prospective randomized study in China L. Wang, Z. Lin, S. Chen, J. Li, C. Chen, Z. Huang, B. Ye, J. Ding, W. Li, L. Wu, Y. Jiang, L. Meng, Q. Du, J. Si Clinical Microbiology and Infection Volume 23, Issue 6, Pages 391-395 (June 2017) DOI: 10.1016/j.cmi.2016.12.032 Copyright © 2017 The Authors Terms and Conditions
Fig. 1 Study design. B-quadruple, bismuth-containing quadruple therapy; OM-triple, omeprazole-based triple therapy; R, randomly assigned; UBT, 13C urea breath test. Clinical Microbiology and Infection 2017 23, 391-395DOI: (10.1016/j.cmi.2016.12.032) Copyright © 2017 The Authors Terms and Conditions
Fig. 2 Patient flowchart. B-quadruple, bismuth-containing quadruple therapy; ITT, intention to treat; OM-triple, omeprazole-based triple therapy; PP, per protocol. Clinical Microbiology and Infection 2017 23, 391-395DOI: (10.1016/j.cmi.2016.12.032) Copyright © 2017 The Authors Terms and Conditions